title: The use of continuous glucose monitoring systems in a pediatric population with type 1 diabetes mellitus in real-life settings: the AWeSoMe Study Group experience.
abstract: OBJECTIVE
  The aim of the study was (a) to compare annual glycemic control in pediatric patients with type 1 diabetes mellitus (T1DM) who used a healthcare-funded continuous glucose monitoring system (RT-CGMS) to that of those who performed self-monitoring blood glucose (SMBG) only, in a real-life setting, and (b) to define parameters associated with compliance and glycemic control.
  
  
  METHODS
  A total of 149 youth with T1DM (52.3 % females), mean age 11.8 ± 3.6 years, and 83 in the CGMS group were followed prospectively for 12 months. Glycemic control parameters and compliance to RT-CGMS were assessed periodically.
  
  
  RESULTS
  Glycemic parameters did not differ significantly between the groups during follow-up periods. The time spent with RT-CGMS decreased and only 38 % used it for more than 75 % of the time during the 12 months (consistent users). Mean HbA1c decreased by 0.27 % in consistent users and increased by 0.21 % among intermittent users (used RT-CGMS less than 75 % of time), p = 0.013. Consistent users were younger 10. 6 ± 4.2 vs. 12.5 ± 3.6, p = 0.07, and had higher frequency of SMBG at baseline, 10.6 ± 4.9 vs. 6.3 ± 2.8, p = 0.011.
  
  
  CONCLUSIONS
  The adoption of RT-CGMS was low, even in a healthcare system that funds its use. Caregivers should consider patient characteristics when recommending RT-CGMS use.
authors.affiliation: Pediatric and Adolescent Diabetes Mellitus Service, Assaf Harofeh Medical Center, 70300, Zerifin, Israel, mariannar@asaf.health.gov.il.
authors.forename: M
authors.initials: M
authors.lastname: Rachmiel
authors.forename: Z
authors.initials: Z
authors.lastname: Landau
authors.forename: M
authors.initials: M
authors.lastname: Boaz
authors.forename: K
authors.initials: K
authors.lastname: Mazor Aronovitch
authors.forename: N
authors.initials: N
authors.lastname: Loewenthal
authors.forename: M
authors.initials: M
authors.lastname: Ben-Ami
authors.forename: Y
authors.initials: Y
authors.lastname: Levy-Shraga
authors.forename: D
authors.initials: D
authors.lastname: Modan-Moses
authors.forename: A
authors.initials: A
authors.lastname: Haim
authors.forename: S
authors.initials: S
authors.lastname: Abiri
authors.forename: O
authors.initials: O
authors.lastname: Pinhas-Hamiel
mesh_terms: D000293:Adolescent; D001786:Blood Glucose / Q000032:analysis* / Q000378:metabolism; D015190:Blood Glucose Self-Monitoring / Q000379:methods; D002648:Child; D002675:Child, Preschool; D003922:Diabetes Mellitus, Type 1 / Q000097:blood*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D011446:Prospective Studies
chemical_list: D001786:Blood Glucose